Difference between revisions of "Resource:E79b824c-1756-40b9-a0d6-80045febf3b8"

From The Embassy of Good Science
Line 2: Line 2:
 
|Resource Type=Cases
 
|Resource Type=Cases
 
|Title=Baltimore Case - In Brief
 
|Title=Baltimore Case - In Brief
|Is About=Three months after a widely-leaked draft report by the Office of Scientific Integrity (OSI) accused an immunologist of fabricating data in a 1986 Cell article, the controversy has become more intense. A series of published statements in Nature has catalyzed a bitter debate within the biomedical community. This is a factual case.
+
|Is About=In 1986, Thereza Imanishi-Kari co-authored a scientific paper on immunology with five other authors including Nobel laureate David Baltimore <ref>Weaver D, Reis MH, Albanese C, Costantini F, Baltimore D, Imanishi-Kari T. Altered repertoire of endogenous immunoglobulin gene expression in transgenic mice containing a rearranged mu heavy chain gene [retracted in: Weaver D, Albanese C, Costantini F, Baltimore D. Cell. 1991 May 17;65(4):536]. Cell. 1986;45(2):247-259. doi:10.1016/0092-8674(86)90389-2.</ref>. Margot O'Toole, who was a postdoc in Imanishi-Kari's laboratory and also acknowledged in the paper “for critical reading of the manuscript”, reported Imanishi-Kari for fabrication after discovering laboratory notebook pages with conflicting data. Baltimore refused to retract the paper and Imanishi-Kari dismisses O'Toole from the laboratory. After a series of published statements in Nature and a bitter debate within the biomedical community <ref>Hamilton D. Baltimore case--in brief. Science. 1991;253(5015):24-5.</ref> , Baltimore and three co-authors then retracted the paper. Baltimore publicly apologized for defense of fabricated data and not taking a whistle-blower's accusations seriously <ref>Shim K. Baltimore regrets fraud: Apologizes for defense of fabricated data. The Tech. 1991;111(25):1-13.</ref> . The Office of Research Integrity (ORI) found Imanishi-Kari guilty for data fabrication and attempts of covering up those fabrications with additional frauds. However, the appeals panel of the Department of Health and Human Services (HHS) ruled that the ORI had failed to prove misconduct by Imanishi-Kari and dismissed all charges against her <ref>Kaiser J, Marshall E. Imanishi-Kari Ruling Slams ORI. Science. 1996;272(5270):1864-6.</ref>. This is a factual case.
 
|Important Because=When an article is published, all authors are responsible for what is written in the paper. If the paper contains fabricated data, all the authors are deemed to be responsible.
 
|Important Because=When an article is published, all authors are responsible for what is written in the paper. If the paper contains fabricated data, all the authors are deemed to be responsible.
|Important For=Researchers
+
|Important For=Researchers; All stakeholders in research; Editors; General public; Research Integrity Officers; Journals
 
}}
 
}}
 
{{Link
 
{{Link

Revision as of 12:26, 15 August 2020

Cases

Baltimore Case - In Brief

What is this about?

In 1986, Thereza Imanishi-Kari co-authored a scientific paper on immunology with five other authors including Nobel laureate David Baltimore [1]. Margot O'Toole, who was a postdoc in Imanishi-Kari's laboratory and also acknowledged in the paper “for critical reading of the manuscript”, reported Imanishi-Kari for fabrication after discovering laboratory notebook pages with conflicting data. Baltimore refused to retract the paper and Imanishi-Kari dismisses O'Toole from the laboratory. After a series of published statements in Nature and a bitter debate within the biomedical community [2] , Baltimore and three co-authors then retracted the paper. Baltimore publicly apologized for defense of fabricated data and not taking a whistle-blower's accusations seriously [3] . The Office of Research Integrity (ORI) found Imanishi-Kari guilty for data fabrication and attempts of covering up those fabrications with additional frauds. However, the appeals panel of the Department of Health and Human Services (HHS) ruled that the ORI had failed to prove misconduct by Imanishi-Kari and dismissed all charges against her [4]. This is a factual case.

Why is this important?

When an article is published, all authors are responsible for what is written in the paper. If the paper contains fabricated data, all the authors are deemed to be responsible.

For whom is this important?

Other information

Virtues & Values
Good Practices & Misconduct
Research Area
  1. Weaver D, Reis MH, Albanese C, Costantini F, Baltimore D, Imanishi-Kari T. Altered repertoire of endogenous immunoglobulin gene expression in transgenic mice containing a rearranged mu heavy chain gene [retracted in: Weaver D, Albanese C, Costantini F, Baltimore D. Cell. 1991 May 17;65(4):536]. Cell. 1986;45(2):247-259. doi:10.1016/0092-8674(86)90389-2.
  2. Hamilton D. Baltimore case--in brief. Science. 1991;253(5015):24-5.
  3. Shim K. Baltimore regrets fraud: Apologizes for defense of fabricated data. The Tech. 1991;111(25):1-13.
  4. Kaiser J, Marshall E. Imanishi-Kari Ruling Slams ORI. Science. 1996;272(5270):1864-6.
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
5.1.6